Market Cap 424.44M
Revenue (ttm) 35.11M
Net Income (ttm) -79.20M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -225.58%
Debt to Equity Ratio 0.45
Volume 400,700
Avg Vol 456,404
Day's Range N/A - N/A
Shares Out 94.32M
Stochastic %K 57%
Beta 0.31
Analysts Strong Sell
Price Target $11.67

Company Profile

X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in phase 3 clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. It has a license agreement with Abbisko Therapeutics Co Ltd. to manufac...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 529 8300
Address:
61 North Beacon Street, 4th Floor, Boston, United States
Pope25
Pope25 May. 4 at 7:11 PM
$XFOR rangebound until ph3 is enrolled. see you in september
0 · Reply
Jeff226
Jeff226 Apr. 29 at 1:14 PM
0 · Reply
DARKP00L
DARKP00L Apr. 29 at 11:32 AM
$XFOR 07:14 on Apr. 29 2026 X4 Pharma Says EC Grants Marketing Authorization For XOLREMDI Capsules For Treatment Of Patients With WHIM Syndrome In EU #tradeideas
0 · Reply
TwongStocks
TwongStocks Apr. 29 at 11:01 AM
$XFOR X4 Pharmaceuticals Announces European Commission Approval of XOLREMDI® (Mavorixafor), the First and Only Authorized Treatment for Patients with WHIM Syndrome in the European Union https://investors.x4pharma.com/news-releases/news-release-details/x4-pharmaceuticals-announces-european-commission-approval
0 · Reply
I_Hate_Stock_Twits
I_Hate_Stock_Twits Apr. 24 at 3:30 PM
$XFOR They did sell the prv and that clown woke DEI woman now ex CEO few off to enjoy their Geneva office overseas to be sure.
0 · Reply
Merlintrader
Merlintrader Apr. 20 at 9:35 PM
$XFOR X4 Pharmaceuticals ( $XFOR): post-approval reset, new management, and a binary-but-cleaner road toward the 4WARD readout https://merlintrader.com/x4-pharmaceuticals-april2026-deepdive/
0 · Reply
smk8706
smk8706 Apr. 19 at 5:26 PM
$XFOR hedge fund buying increased by 10 million... good/bad? Whats everyones first thought when they read this?
0 · Reply
Stephanovich7654568
Stephanovich7654568 Apr. 7 at 3:13 PM
$RCKT $XFOR . XFOR is an eternal loser. Look at how many stock split events they went trought. RCKT has a chance.
0 · Reply
Zkoko_Bio
Zkoko_Bio Apr. 7 at 11:09 AM
$RCKT don't expect much from PRVs. Remember for example when $XFOR sold its PRV for nearly as much as its MC back then? Stock price just acted as if nothing happened...
1 · Reply
focafoca99
focafoca99 Apr. 1 at 9:51 PM
$XFOR reported inducement grants covering 32,000 shares for new employees.
0 · Reply
Latest News on XFOR
X4 Pharmaceuticals reports Q1 EPS (16c), consensus (20c)

2026-05-07T06:33:22.000Z - 6 days ago

X4 Pharmaceuticals reports Q1 EPS (16c), consensus (20c)


X4 Pharmaceuticals files $300M mixed securities shelf

2026-05-07T01:47:41.000Z - 6 days ago

X4 Pharmaceuticals files $300M mixed securities shelf


X4 Pharmaceuticals announces EC approval of Xolremdi

2026-04-29T16:37:43.000Z - 13 days ago

X4 Pharmaceuticals announces EC approval of Xolremdi


X4 Pharmaceuticals reports Q4 EPS (22c), consensus (35c)

2026-03-17T11:20:56.000Z - 2 months ago

X4 Pharmaceuticals reports Q4 EPS (22c), consensus (35c)


X4 Pharmaceuticals sees cash runway through 2028

2026-03-17T11:20:44.000Z - 2 months ago

X4 Pharmaceuticals sees cash runway through 2028


X4 Pharmaceuticals initiated with a Buy at Guggenheim

2026-03-09T10:51:50.000Z - 2 months ago

X4 Pharmaceuticals initiated with a Buy at Guggenheim


X4 Pharmaceuticals reports Q3 EPS (69c), consensus (84c)

2025-11-05T12:05:28.000Z - 6 months ago

X4 Pharmaceuticals reports Q3 EPS (69c), consensus (84c)


X4 Pharmaceuticals 45.87M share Spot Secondary priced at $2.85

2025-10-24T10:41:05.000Z - 7 months ago

X4 Pharmaceuticals 45.87M share Spot Secondary priced at $2.85


X4 Pharmaceuticals Earnings Call Transcript: Q1 2025

May 1, 2025, 8:30 AM EDT - 1 year ago

X4 Pharmaceuticals Earnings Call Transcript: Q1 2025


X4 Pharmaceuticals Announces Reverse Stock Split

Apr 24, 2025, 8:00 AM EDT - 1 year ago

X4 Pharmaceuticals Announces Reverse Stock Split


X4 Pharmaceuticals Earnings Call Transcript: Q4 2024

Mar 25, 2025, 8:30 AM EDT - 1 year ago

X4 Pharmaceuticals Earnings Call Transcript: Q4 2024


X4 Pharmaceuticals Earnings Call Transcript: Q3 2024

Nov 13, 2024, 8:00 AM EST - 1 year ago

X4 Pharmaceuticals Earnings Call Transcript: Q3 2024


X4 Pharmaceuticals Earnings Call Transcript: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 1 year ago

X4 Pharmaceuticals Earnings Call Transcript: Q2 2024


X4 Pharmaceuticals Transcript: Study Update

Jun 27, 2024, 8:00 AM EDT - 2 years ago

X4 Pharmaceuticals Transcript: Study Update


X4 Pharmaceuticals Earnings Call Transcript: Q1 2024

May 7, 2024, 8:30 AM EDT - 2 years ago

X4 Pharmaceuticals Earnings Call Transcript: Q1 2024


X4 Pharmaceuticals Transcript: FDA Announcement

Apr 29, 2024, 8:30 AM EDT - 2 years ago

X4 Pharmaceuticals Transcript: FDA Announcement


X4 Pharmaceuticals Earnings Call Transcript: Q4 2023

Mar 21, 2024, 8:30 AM EDT - 2 years ago

X4 Pharmaceuticals Earnings Call Transcript: Q4 2023


X4 Pharmaceuticals Earnings Call Transcript: Q3 2023

Nov 9, 2023, 8:30 AM EST - 2 years ago

X4 Pharmaceuticals Earnings Call Transcript: Q3 2023


Pope25
Pope25 May. 4 at 7:11 PM
$XFOR rangebound until ph3 is enrolled. see you in september
0 · Reply
Jeff226
Jeff226 Apr. 29 at 1:14 PM
0 · Reply
DARKP00L
DARKP00L Apr. 29 at 11:32 AM
$XFOR 07:14 on Apr. 29 2026 X4 Pharma Says EC Grants Marketing Authorization For XOLREMDI Capsules For Treatment Of Patients With WHIM Syndrome In EU #tradeideas
0 · Reply
TwongStocks
TwongStocks Apr. 29 at 11:01 AM
$XFOR X4 Pharmaceuticals Announces European Commission Approval of XOLREMDI® (Mavorixafor), the First and Only Authorized Treatment for Patients with WHIM Syndrome in the European Union https://investors.x4pharma.com/news-releases/news-release-details/x4-pharmaceuticals-announces-european-commission-approval
0 · Reply
I_Hate_Stock_Twits
I_Hate_Stock_Twits Apr. 24 at 3:30 PM
$XFOR They did sell the prv and that clown woke DEI woman now ex CEO few off to enjoy their Geneva office overseas to be sure.
0 · Reply
Merlintrader
Merlintrader Apr. 20 at 9:35 PM
$XFOR X4 Pharmaceuticals ( $XFOR): post-approval reset, new management, and a binary-but-cleaner road toward the 4WARD readout https://merlintrader.com/x4-pharmaceuticals-april2026-deepdive/
0 · Reply
smk8706
smk8706 Apr. 19 at 5:26 PM
$XFOR hedge fund buying increased by 10 million... good/bad? Whats everyones first thought when they read this?
0 · Reply
Stephanovich7654568
Stephanovich7654568 Apr. 7 at 3:13 PM
$RCKT $XFOR . XFOR is an eternal loser. Look at how many stock split events they went trought. RCKT has a chance.
0 · Reply
Zkoko_Bio
Zkoko_Bio Apr. 7 at 11:09 AM
$RCKT don't expect much from PRVs. Remember for example when $XFOR sold its PRV for nearly as much as its MC back then? Stock price just acted as if nothing happened...
1 · Reply
focafoca99
focafoca99 Apr. 1 at 9:51 PM
$XFOR reported inducement grants covering 32,000 shares for new employees.
0 · Reply
MrFister1661
MrFister1661 Apr. 1 at 1:35 AM
$XFOR bounced off that $4 floor pretty well
0 · Reply
Zkoko_Bio
Zkoko_Bio Mar. 27 at 3:48 PM
$XFOR and this useless pos @Steve_TheBull_Rogers still attacked me for telling the truth
1 · Reply
MrBruceWayne
MrBruceWayne Mar. 26 at 3:35 PM
🚨 BUY ALERT $XFOR
2 · Reply
Love_To_Learn
Love_To_Learn Mar. 26 at 2:55 PM
$XFOR ME OFF LOWS TODAY ALSO 4.1 OTHER DAY
0 · Reply
Duskfall
Duskfall Mar. 20 at 4:18 PM
$XFOR Niceee 👍
0 · Reply
captainjoerg
captainjoerg Mar. 20 at 3:01 PM
$OCGN good that my $XFOR is running
0 · Reply
Duskfall
Duskfall Mar. 20 at 2:51 PM
$XFOR 📈✅
1 · Reply
Duskfall
Duskfall Mar. 20 at 2:29 AM
$XFOR Shall we go up to five dollars now?
0 · Reply
MrFister1661
MrFister1661 Mar. 19 at 11:53 PM
$XFOR been waiting for this one, averaged in at $1.82 over last summer. New leadership has been really good and I'm excited for this to progress
0 · Reply
MaddyLeo
MaddyLeo Mar. 19 at 11:00 PM
$XFOR top recommendation by Chat Gpt , ctalyst coming soon
0 · Reply
MaddyLeo
MaddyLeo Mar. 19 at 10:25 PM
$XFOR i think i m early here🙈🙈
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 19 at 1:12 AM
$XFOR RSI: 61.17, MACD: 0.1309 Vol: 0.43, MA20: 3.66, MA50: 3.68 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply